Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Net Income: 2020-2025

Historic Net Income for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$29.4 million.

  • Caribou Biosciences' Net Income rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • Latest data reveals that Caribou Biosciences reported Net Income of -$29.4 million as of Q3 2025, which was up 38.21% from -$47.6 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Net Income peaked at -$13.2 million during Q1 2021, and registered a low of -$47.6 million during Q2 2025.
  • Over the past 3 years, Caribou Biosciences' median Net Income value was -$38.2 million (recorded in 2024), while the average stood at -$36.6 million.
  • As far as peak fluctuations go, Caribou Biosciences' Net Income slumped by 664.48% in 2021, and later soared by 44.86% in 2023.
  • Caribou Biosciences' Net Income (Quarterly) stood at -$18.5 million in 2021, then slumped by 65.47% to -$30.6 million in 2022, then dropped by 22.45% to -$37.4 million in 2023, then declined by 3.83% to -$38.9 million in 2024, then rose by 23.11% to -$29.4 million in 2025.
  • Its last three reported values are -$29.4 million in Q3 2025, -$47.6 million for Q2 2025, and -$42.9 million during Q1 2025.